Westlake BioPartners
westlakebio.com
Biotechnology
Venture Capital
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Investor profile
Venture capitalInvestments
9
7 of them startups
Hiring now
3
16 open roles
Exits
2
Focusshare of its companies
Biotechnology 86%Health Care 71%
Where its companies are
United States 22%Canada 11%
Stage of its companies
Series B 67%Series A 33%
Its companies, the freshest money firstAll 9 investments
Allrock BioSeries A $50M · 13 mo ago
AlumisVenture round $40M · 2 yr ago · 4 roles
Kyverna Therapeutics10 roles
Borealisbio2 roles
Capsida Biotherapeutics
Electra Therapeutics
Arsenal Bio
3T Biosciences
Hiring fastestroles opened in 30 days
Co-investorscompanies they hold together
OrbiMed Similar investorstheir companies share markets and countries
EcoR1 Capital
SR One
Fund+
Taiho Ventures
ARCH Venture Partners
Atlas Venture
Nextech Invest
Flagship PioneeringSources: its portfolio page, read Nov 3
Overview
Westlake BioPartners is a life science venture capital firm that builds and funds biotechnology companies around experienced scientific entrepreneurs. It invests at the earliest stages, often co-founding or incubating drug discovery and therapeutics startups, with a strong presence in the Los Angeles and Southern California biotech ecosystem. The firm was founded in 2018 by Beth Seidenberg and Sean Harper, the former head of research and development at Amgen, and is based in Westlake Village, California.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Los Angeles
United States
HQ